UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045739
Receipt number R000052217
Scientific Title Comparative examination of the validity of the preservation method of treatment to a vertebral fracture
Date of disclosure of the study information 2021/11/30
Last modified on 2024/03/22 11:52:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparative examination of the validity of the preservation method of treatment to a vertebral fracture

Acronym

vertebral fracture

Scientific Title

Comparative examination of the validity of the preservation method of treatment to a vertebral fracture

Scientific Title:Acronym

vertebral fracture

Region

Japan


Condition

Condition

vertebral fracture

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Preservation method of treatment is often generally chosen by a vertebral fracture, but it's the purpose of this research to make the validity by each equipment difference clear and to compare and examine improvement of the degree of satisfaction of the patient because the validity of the treatment by each equipment difference isn't clear. I can think these inspection results will be some help of choice of preservation treatment and improvement of patient satisfaction to a vertebral fracture.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Vertebral crush rate which depends on backbone x-ray inspection in 3 months after the study starting time and starting (the change amount)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

MAXBELT

Interventions/Control_2

Damen corset

Interventions/Control_3

Jewett type

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) the patient preservation treatment was diagnosed as a new vertebral fracture, and by whom was chosen
2) the age of the time of the agreement merit, more than 65-year-old patient (I don't ask about the gender.)
3)the patient who could get documentary consent by free will of the the back and the patient person himself which had the enough explanation in case of participation of this research

Key exclusion criteria

1)dementia
2)spirit disease
3)The patient for whom walking was difficult before vertebral fracture
4)additionally the patient who judged that a study person in change was unsuitable as a subject of research person

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Mochizuki

Organization

Kamagaya General Hospital

Division name

Plastic surgery

Zip code

273-0121

Address

929-6 Hatsutomi, Kamagaya-City Chiba

TEL

047-498-8266

Email

chiken@kamagaya-hp.jp


Public contact

Name of contact person

1st name Takeshi
Middle name
Last name Mochizuki

Organization

Kamagaya General Hospital

Division name

Plastic surgery

Zip code

273-0121

Address

929-6 Hatsutomi, Kamagaya-City Chiba

TEL

047-498-8266

Homepage URL


Email

chiken@kamagaya-hp.jp


Sponsor or person

Institute

Kamagaya General Hospital

Institute

Department

Personal name



Funding Source

Organization

Kamagaya General Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The TOKUSHUKAI GROUP ETHICS COMMITTEE

Address

1-3-1 Kudanminami, Chiyoda-ku, Tokyo

Tel

03-3263-4801

Email

mirai-ec4@mirai-iryo.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 11 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 10 Month 01 Day

Date of IRB

2022 Year 01 Month 26 Day

Anticipated trial start date

2022 Year 01 Month 27 Day

Last follow-up date

2026 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 10 Month 13 Day

Last modified on

2024 Year 03 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052217


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name